NCT07310004 Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
| NCT ID | NCT07310004 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jonsson Comprehensive Cancer Center |
| Condition | Breast Biopsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2026-01-20 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2026-01-20 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effectiveness of a Virtual Reality (VR) application computer simulation \[(CS) VR Mindful Meditation App')\] versus music relaxation in reducing anxiety and pain in women undergoing breast biopsies. Participants will be randomized into three groups: VR, music relaxation, or standard care. Anxiety and pain will be measured using validated scales, and an optional physiological marker may be collected to assess stress levels. Participants will also be asked about their satisfaction with the intervention received, along with procedure-specific questions.
Eligibility Criteria
Inclusion Criteria: * Females aged 18 years or older. * Scheduled for an ultrasound-guided or stereotactic breast biopsy. * Capable of understanding and providing informed consent. Exclusion Criteria: * Individuals with a history of epilepsy, motion sickness, or severe cognitive impairment (for the VR group). * Use of anxiolytic medication immediately prior to the biopsy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07310004 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Biopsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07310004 currently recruiting?
Yes, NCT07310004 is actively recruiting participants. Contact the research team at taylorjohnson@mednet.ucla.edu for enrollment information.
Where is the NCT07310004 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07310004 clinical trial?
NCT07310004 is sponsored by Jonsson Comprehensive Cancer Center. The trial plans to enroll 600 participants.